Positions

Research Areas research areas

Overview

  • Scientifically, my expertise lies in the areas of cytokine actions; erythropoiesis & hematopoiesis; and progenitor cell biology. To date, ~80 major publications have been contributed; independent NIH funding has been in-place since 1987; and ~35 scientists have been trained and placed. Administratively, I previously directed Penn State’s Immunobiology Program. While at the Maine Medical Center Research Institute, I served as Director of the COBRE Center of Excellence in Stem & Progenitor Cell Biology and Regenerative Medicine (2005-2017) and as a member of the Internal Steering Committee for MMCRI’s Phase-III COBRE in Vascular Biology. Nationally, I serve frequently on NIH special emphasis and Center review panels, contribute to workshops, and have served as a full-member of NIH’s Study Section in Molecular and Cellular Hematology (and previously, as a regular member of HEM2 Study Section). I also review frequently for Nature Medicine, Science, Blood, NEJM, Experimental Hematology, and have worked in sponsored and collaborative programs with a number of biopharma entities (eg, GSK, Centocor, Amgen, Affymax, RW Johnson, Adeptrix, Cell Signaling Technology).
  • Publications

    Academic Article

    Year Title
    2018 Ineffective erythropoiesis of TET2 deficiencyBlood.  132:2320-2321. 2018
    2018 Optimizing Workflows for LC/MS Analysis of Co-Immunoprecipitated Protein Complexes - "Soap Opera(tions)".Journal of Proteomics and Bioinformatics.  11:1-3. 2018
    2017 Novel roles for podocalyxin in regulating stress myelopoiesis, Rap1a, and neutrophil migration.Experimental Hematology.  50:77-83.e6. 2017
    2017 Governing roles for Trib3 pseudokinase during stress erythropoiesis.Experimental Hematology.  49:48-55.e5. 2017
    2016 A dimeric peptide with erythropoiesis-stimulating activity uniquely affects erythropoietin receptor ligation and cell surface expression.Experimental Hematology.  44:765-769.e1. 2016
    2016 Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.Expert Opinion on Therapeutic Targets.  20:287-301. 2016
    2015 Emerging EPO and EPO receptor regulators and signal transducers.Blood.  125:3536-3541. 2015
    2015 RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.Journal of Experimental Medicine.  212:971. 2015
    2014 Brief report: serpin Spi2A as a novel modulator of hematopoietic progenitor cell formation.Stem Cells.  32:2550-2556. 2014
    2014 Peginesatide and erythropoietin stimulate similar erythropoietin receptor mediated signal transduction and gene induction events (vol 40, pg 575, 2012)Experimental Hematology.  42:838-838. 2014
    2014 RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.Journal of Experimental Medicine.  211:1715-1722. 2014
    2014 Erythroid mRNA processing: a "splice of life".Blood.  124:474-475. 2014
    2014 Death associated protein kinase 2 is expressed in cortical interstitial cells of the mouse kidney.BMC Research Notes.  7:345. 2014
    2014 Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins (vol 210, pg 225, 2013)Journal of Experimental Medicine.  211:381-381. 2014
    2013 Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins.Journal of Experimental Medicine.  210:225-232. 2013
    2012 Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.Experimental Hematology.  40:575-587. 2012
    2012 Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.Blood.  119:5522-5531. 2012
    2012 Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.PLoS ONE.  7:e38530. 2012
    2012 Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.PLoS ONE.  7:e29064. 2012
    2011 Eugene Goldwasser (1922-2010).Nature Nature: New biology.  470:40. 2011
    2010 During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool.Blood.  116:5334-5346. 2010
    2010 Micro-mismanaging sickle cell stress.Blood.  116:4040-4042. 2010
    2010 Erythropoietin receptor response circuits.Current Opinion in Hematology.  17:169-176. 2010
    2010 BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway.Journal of Cellular Biochemistry.  109:363-374. 2010
    2009 CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools.Blood.  113:4955-4962. 2009
    2009 A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.Experimental Hematology.  37:159-171. 2009
    2008 DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia.Journal of Biological Chemistry.  283:36665-36675. 2008
    2008 JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.American Journal of Physiology - Renal Fluid and Electrolyte Physiology American Journal of Physiology - Renal Physiology.  295:F1689-F1695. 2008
    2008 An in vivo reporter of BMP signaling in organogenesis reveals targets in the developing kidney.BMC Developmental Biology.  8:86. 2008
    2008 Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2.Blood.  112:886-890. 2008
    2008 KIT associated intracellular tyrosines play an essential role in EpoR co-signaling.Cellular Signalling.  20:1513-1520. 2008
    2008 EPO receptor circuits for primary erythroblast survival.Blood.  111:5390-5399. 2008
    2007 EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts.Blood.  110:2361-2370. 2007
    2007 Erythropoietin modulation of podocalyxin and a proposed erythroblast niche.Blood.  110:509-518. 2007
    2006 Lyn kinase promotes erythroblast expansion and late-stage development.Blood.  108:1524-1532. 2006
    2006 Core erythropoietin receptor signals for late erythroblast development.Blood.  107:2662-2672. 2006
    2006 Erythropoietin-dependent erythropoiesis: New insights and questions.Blood Cells, Molecules, and Diseases.  36:232-238. 2006
    2006 Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.Journal of Clinical Investigation.  116:683-694. 2006
    2005 DYRK gene structure and erythroid-restricted features of DYRK3 gene expression.Genomics.  85:117-130. 2005
    2003 Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.Blood.  102:3147-3153. 2003
    2003 Roles for an EPO receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kitJournal of Biological Chemistry.  278:40702-40709. 2003
    2002 DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival.Journal of Biological Chemistry.  277:47052-47060. 2002
    2002 Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.Blood.  99:898-904. 2002
    2001 An optimized system for studies of EPO-dependent murine pro-erythroblast development.Experimental Hematology.  29:1278-1288. 2001
    2001 Integrative signaling by minimal erythropoietin receptor forms and c-Kit.Journal of Biological Chemistry.  276:8995-9002. 2001
    2001 mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development.Blood.  97:901-910. 2001
    2000 GATA-1- and FOG-dependent activation of megakaryocytic alpha IIB gene expression.Journal of Biological Chemistry.  275:34114-34121. 2000
    2000 Intron 1 elements promote erythroid-specific GATA-1 gene expression.Journal of Biological Chemistry.  275:22969-22977. 2000
    2000 Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death.Oncogene.  19:3684-3692. 2000
    2000 Subtraction cloning and initial characterization of novel epo-immediate response genes.Cytokine.  12:845-857. 2000
    1999 Signal transduction in the erythropoietin receptor system.Experimental Cell Research.  253:143-156. 1999
    1999 A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development.Blood.  94:3381-3387. 1999
    1999 pIRES-CD4t, a dicistronic expression vector for MACS- or FACS-based selection of transfected cells.BioTechniques.  26:683-688. 1999
    1998 Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.Blood.  92:1104-1118. 1998
    1998 GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells.Molecular and Cellular Biology.  18:3278-3288. 1998
    1997 Mechanisms of stem cell factor and erythropoietin proliferative co-signaling in FDC2-ER cells.Blood.  90:3533-3545. 1997
    1997 Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.Blood.  90:2175-2187. 1997
    1997 Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain.Journal of Biological Chemistry.  272:11176-11184. 1997
    1997 Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.Growth Factors.  14:161-176. 1997
    1996 The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera.Journal of Biological Chemistry.  271:16472-16476. 1996
    1996 Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.Molecular Endocrinology.  10:847-856. 1996
    1996 Functional interaction of GATA1 with erythroid Krüppel-like factor and Sp1 at defined erythroid promoters.Blood.  87:1793-1801. 1996
    1995 Signal transduction by the receptors for thrombopoietin (c-mpL) and interleukin-3 in hematopoietic and nonhematopoietic cells.Blood.  86:557-571. 1995
    1995 Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2.Journal of Biological Chemistry.  270:14500-14504. 1995
    1995 Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway.Journal of Biological Chemistry.  270:11055-11061. 1995
    1995 Erythropoietin-induced transcription at the murine beta maj-globin promoter. A central role for GATA-1.Journal of Biological Chemistry.  270:6619-6627. 1995
    1994 In vitro transcription of erythroid promoters using baculoviral-expressed human GATA-1: purification, physicochemistry, and activities.Protein Expression and Purification.  5:587-594. 1994
    1994 Steel factor affects SCL expression during normal erythroid differentiation.Blood.  84:2971-2976. 1994
    1994 Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation.Biochemical and Biophysical Research Communications.  204:278-283. 1994
    1994 Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2.Journal of Biological Chemistry.  269:21411-21414. 1994
    1994 The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells.Journal of Biological Chemistry.  269:18291-18294. 1994
    1993 Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain.Blood.  82:3530-3538. 1993
    1993 RECEPTOR-TARGETED TRANSFECTION USING STABLE MALEIMIDO-TRANSFERRIN THIO-POLY-L-LYSINE CONJUGATES (VOL 213, PG 97, 1993)Analytical Biochemistry.  214:588-588. 1993
    1993 Signal transduction in the erythropoietin receptor system.Stem Cells.  11:381-392. 1993
    1993 Receptor-targeted transfection using stable maleimido-transferrin/thio-poly-L-lysine conjugates.Analytical Biochemistry.  213:97-103. 1993
    1993 Expression of rat liver phenylalanine hydroxylase in insect cells and site-directed mutagenesis of putative non-heme iron-binding sitesJournal of Biological Chemistry.  268:8046-8052. 1993
    1992 Phosphorylatable and epitope-tagged human erythropoietins: utility and purification of native baculovirus-derived forms.Protein Expression and Purification.  3:461-469. 1992
    1992 Cytokine-induced phosphorylation of pp100 in FDC-ER cells is at tyrosine residues.Biochemical and Biophysical Research Communications.  188:1040-1046. 1992
    1992 Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization.Molecular and Cellular Biology.  12:4553-4561. 1992
    1992 Interleukin 3, granulocyte-macrophage colony-stimulating factor, and transfected erythropoietin receptors mediate tyrosine phosphorylation of a common cytosolic protein (pp100) in FDC-ER cells.Journal of Biological Chemistry.  267:17055-17060. 1992
    1991 Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor.Proceedings of the National Academy of Sciences of the United States of America.  88:4801-4805. 1991
    1991 Proliferative action of erythropoietin is associated with rapid protein tyrosine phosphorylation in responsive B6SUt.EP cells.Journal of Biological Chemistry.  266:609-614. 1991
    1989 BIOTINYLATED ERYTHROPOIETIN - REPLYBlood.  74:2772-2773. 1989
    1989 Biotinylated recombinant human erythropoietins: bioactivity and utility as receptor ligand.Blood.  74:952-958. 1989
    1989 High-level expression and purification of a recombinant human erythropoietin produced using a baculovirus vector.Blood.  74:652-657. 1989
    1987 Active human erythropoietin expressed in insect cells using a baculovirus vector: a role for N-linked oligosaccharide.Biochimica et Biophysica Acta - General Subjects.  910:224-232. 1987
    1987 Site-specific antibodies to human erythropoietin: immunoaffinity purification of urinary and recombinant hormone.Biochimica et Biophysica Acta - General Subjects.  913:170-178. 1987
    1987 Erythropoietin rapidly alters phosphorylation of pp43, an erythroid membrane protein.Journal of Biological Chemistry.  262:2933-2936. 1987
    1987 PURIFICATION OF 2 DISTINCT OOCYTE VITELLINS AND IDENTIFICATION OF THEIR CORRESPONDING VITELLOGENINS IN FAT-BODY AND HEMOLYMPH OF BLABERUS-DISCOIDALISInsect Biochemistry.  17:189-198. 1987
    1986 Processing of pro-vitellogenin in insect fat body: a role for high-mannose oligosaccharide.Developmental Biology.  116:422-430. 1986
    1986 Hybridoma production by simplified avidin-mediated electrofusion.Journal of Immunological Methods.  90:173-177. 1986
    1986 Detection of low-density cell-surface molecules using biotinylated fluorescent microspheres.Biochimica et Biophysica Acta - General Subjects.  857:61-67. 1986
    1985 Identification of a surface epitope of human erythropoietin with anti-peptide antibodies.Biochemical and Biophysical Research Communications.  129:707-713. 1985
    1985 STRUCTURE AND EMBRYONIC DEGRADATION OF 2 NATIVE VITELLINS IN THE COCKROACH, PERIPLANETA-AMERICANAInsect Biochemistry.  15:259-275. 1985
    1984 A comparative study of the size-heterogeneous high mannose oligosaccharides of some insect vitellins.Comparative Biochemistry and Physiology -- Part B: Biochemistry and.  79:379-390. 1984
    Novel EPO/EPOR/JAK2 targets and signal transduction pathways revealed by phospho-PTM proteomic profilingBlood

    Conference Proceeding

    Year Title
    2016 "C1ORF150", a Novel Mediator of EPO/EPOR/JAK2 Dependent Human Erythroid Progenitor Cell FormationBlood. 2016
    2015 EPO Modulation of Thioredoxin Interacting Protein (TXNIP), and Key Roles for TXNIP during EPO-Dependent Human Erythroid Progenitor Cell Growth and DevelopmentBlood. 2015
    2015 Podocalyxin Negatively Regulates Stress Myelopoiesis, Directly Binds Rap-1A and Modulates Its G-CSF-Induced ActivityBlood. 2015
    2014 Discovery of Novel EPO/EPOR/JAK2 Targets and Signal Transduction Factors Via Proteomic-Based Interrogations of Post-Translational Motif ModificationsBlood. 2014
    2013 Ligand-Regulated and Developmental Stage-Specific Expression Of The EPO Receptor During Human Erythroid Progenitor Cell FormationBlood. 2013
    2013 Trib2 Pseudokinase Marks Early CMP Progenitors, and Promotes Granulocytic Plus Erythroid Progenitor Cell FormationBlood. 2013
    2013 PEGINESATIDE ENHANCES ERYTHROID PROGENITOR RECRUITMENT AND CELL SURFACE ERYTHROPOIETIN RECEPTOR EXPRESSIONNephrology Dialysis Transplantation. 240-240. 2013
    2012 Erythropoietin-Directed Erythropoiesis Depends Upon Serpin Inhibition of Erythroblast Lysosomal CathepsinsBlood. 2012
    2012 Hematopoietic Lineage Selective Roles for Trib Pseudokinases Post Bone Marrow TransplantationBlood. 2012
    2012 The Erythropoiesis Stimulating Agent Omontys/Peginesatide up-Modulates Erythroid Progenitor Formation, and Cell Surface Erythropoietin Receptor LevelsBlood. 2012
    2012 EXTENDED FUNCTIONAL LIFESPAN OF THE ERYTHROPOIETIN RECEPTOR (EPOR) FOLLOWING STIMULATION WITH PEGINESATIDENephrology Dialysis Transplantation. 78-78. 2012
    2011 "RHEX-26", a Novel EPO/EPOR-Regulated Mediator of Human Erythroid Progenitor Cell ExpansionBlood. 313-313. 2011
    2010 Dynamic Erythropoietin Receptor Trafficking Within Cell Surface, and Intracellular PoolsBlood. 850-850. 2010
    2010 Epo Engages a Tnfr-13c Pathway to Advance for Primary Bone Marrow (Pro)Erythroblast DevelopmentBlood. 1721-1721. 2010
    2009 BMP Signaling Is Crucial for Regulation Vascular Progenitor Development in Human Embryonic Stem Cells.Blood. 1183-1184. 2009
    2009 Spry1 Plays Selective Hematopoietic Roles as An Erythropoietin - Modulated Positive Regulator of ErythropoiesisBlood. 321-322. 2009
    2009 TRIB3 Pseudokinase Is Induced Via An EPO/EPOR/STAT5 Pathway, Markedly up-Modulated in Late-Stage Erythroblasts, and Plays An Essential Non-Redundant Role During Stress ErythropoiesisBlood. 786-786. 2009
    2008 Non-Redundant Roles for an Epo/EpoR/STAT5 Regulated Intracellular Serpin, Serpina-3G, during Epo- and Anemia- Induced ErythropoiesisBlood. 329-329. 2008
    2007 GSK626616: A DYRK3 inhibitor as a potential new therapy for the treatment of anemiaBlood. 156A-157A. 2007
    2006 Epo modulation of cell cycle regulatory genes via PY343/STAT5 and PI3K pathways in primary erythroblasts.Blood. 333A-333A. 2006
    2006 Epo receptor circuits to Irs2, Foxo3a, Trb3 and Bim 1 expression, and erythroblast survival.Blood. 197A-197A. 2006
    2006 Erythropoietin modulation of podocalyxin within an erythroblast niche.Blood. 404A-404A. 2006
    2006 Transgenic GATA1ie3.9int - DAPK2 mice exhibit low-grade anemia, deficient stress erythropoiesis, and compromised erythroblast survival.Blood. 377A-378A. 2006
    2004 Core epo receptor signaling circuits in adult bone marrow-derived primary pro-erythroblasts.Blood. 450A-451A. 2004
    2004 Death associated protein kinase 2 (DAPK2): A novel Epo-modulated apoptotic regulator of late erythropoiesis.Blood. 168A-168A. 2004
    2004 Kit PY567-directed signals are important for efficient erythroid progenitor cell proliferation and survival, and are attenuated by Kit PY569.Blood. 596A-596A. 2004
    2004 Lyn kinase supports primary erythroid progenitor cell development.Blood. 451A-451A. 2004
    2003 Assisting mechanisms during PY-null Epo receptor allele dependent steady-state erythropoiesis.Blood. 171B-171B. 2003
    2003 Stress erythropoiesis is not efficiently supported by a minimal Epo receptor phosphotyrosine-null allele.Blood. 510A-510A. 2003
    2002 DYRK3 activation mechanisms, PKA/CREB engagement and modulation of progenitor cell survival.Blood. 523A-523A. 2002
    2002 Dynamics of pro-erythroblasts growth and differentiation revealed through gene profiling.Blood. 167B-168B. 2002
    2002 Roles for Epo receptor Y343 (and Stat5) in Kit synergy.Blood. 523A-523A. 2002
    2001 Purification of developmentally staged erythroid progenitor cells in numbers sufficient for gene profiling of CFUe development.Blood. 132B-132B. 2001
    2001 SCF/Epo synergy in primary CFUe is mediated efficiently by Epo receptor phosphotyrosine-independent mechanisms.Blood. 795A-795A. 2001
    2000 An optimized primary cell system for investigators of regulated erythropoiesis: Developmentally synchronized splenic erythroid progenitor cells from thiamphenicol-treated transgenic mice.Blood. 678A-678A. 2000
    2000 Erythroid-restricted expression and repressive role for mDYRK3 dual-specificity kinase in CFUe development.Blood. 667A-667A. 2000
    1999 Critical, concentrations of FOG are required for alpha IIb gene activation via both GATA-1-dependent, and independent mechanisms.Blood. 260A-260A. 1999
    1999 SCF synergizes with Epo via Epo receptor (p)y-dependent and -independent routes, selectively enhances Epo/Jak2/STAT5-dependent bclx & bcl2 gene transcription, and is the primary activator of Erks.Blood. 152B-152B. 1999
    1998 Regulation of GATA-1 gene expression: Roles for FOG, GATA-1, EPO, and novel activating and repressing cis-domains.Blood. 155B-155B. 1998
    1998 Subtraction cloning and initial characterization of novel EPO-response genes.Blood. 67A-67A. 1998
    1997 Co-expression of GATA-1 and the Epo receptor in myeloid FDCW2 cells prolongs the cell cycle at G(1), attenuates proliferation and activates endogenous erythroid gene expression.Blood. 747-747. 1997
    1997 Pim1 inhibits cell death: Induction of Pim1 and Pim2 transcription via a minimal Epo receptor form and modulation of apoptosis upon the deregulated expression of Pim1.Blood. 1370-1370. 1997
    1996 Epo-induced hemoglobinization of SKT6 cells is blocked by a dominant-negative form of STAT5.Blood. 199-199. 1996
    1995 EPO signaling via minimal mitogenic receptor forms, and via STAT factors in differentiating erythroid SKT6-40 cells.Blood. 54-54. 1995
    1994 ROLES FOR JAK2 KINASE IN EPO-INDUCED MITOGENESIS, INHIBITED APOPTOSIS, AND ERYTHROID-DIFFERENTIATIONBlood. A223-A223. 1994
    1994 ASSOCIATION OF P85/PI3-K WITH THE EPO RECEPTOR WITHIN THE EXTENDED BOX-2 DOMAIN, AND POSSIBLE ROLES FOR JAK-2 IN PI3-K ACTIVATIONJournal of Cellular Biochemistry. 32-32. 1994
    1994 UNIQUE CIS-ELEMENTS OF THE MURINE BETA(MAJ) GLOBIN PROMOTER MEDIATE EPO-INDUCED TRANSCRIPTION IN RESPONSIVE J2E CELLS - A CENTRAL ROLE FOR GATA-1Journal of Cellular Biochemistry. 25-25. 1994
    1993 ASSOCIATION OF P85/P13-K WITH THE EPO RECEPTOR WITHIN THE EXTENDED BOX-2 DOMAIN, AND POSSIBLE ROLES FOR JAK-2 IN P13-K ACTIVATIONBlood. A227-A227. 1993
    1991 BIOACTIVE EPO FUSION PROTEINS - MODELS FOR OPTIMIZING BACULOVIRUS-MEDIATED EXPRESSION SYSTEMSEIGHTH INTERNATIONAL CONFERENCE ON INVERTEBRATE AND FISH TISSUE CULTURE. 140-146. 1991
    1986 MODULATION OF ERYTHROID MEMBRANE-PROTEIN PHOSPHORYLATION IS AN EARLY EVENT IN THE MECHANISM OF ACTION OF ERYTHROPOIETINCLINICAL RESEARCH. A454-A454. 1986
    1985 DETECTION OF LOW-DENSITY CELL-SURFACE MOLECULES USING BIOTINYLATED FLUORESCENT MICROSPHERESFASEB Journal. 1434-1434. 1985
    1985 LABELING OF RARE CELL-SURFACE MOLECULES USING MICROSPHERES AND FLUORESCENT FLOW-CYTOMETRYCLINICAL RESEARCH. A357-A357. 1985
    1983 DEVELOPMENTAL HETEROGENEITY OF JUVENILE-HORMONE BINDING-SITES IN INSECT FAT-BODY CYTOSOLFASEB Journal. 1878-1878. 1983
    1983 TUNICAMYCIN INHIBITION OF HIGH MANNOSE OLIGOSACCHARIDE ATTACHMENT TO AN INSECT VITELLOGENIN ABOLISHES ITS NORMAL PROCESSING AND SECRETION FROM THE FAT-BODYFASEB Journal. 2083-2083. 1983

    Teaching Activities

  • Adv Rsrch Exp/MCBS Taught course 2019
  • Contemp Top Molec/Cell/Biomed Taught course 2019
  • Seminar Taught course 2019
  • Contemp Top Molec/Cell/Biomed Taught course 2018
  • Rsrch Exp/MCBS Taught course 2018
  • Seminar Taught course 2018
  • Tissue Engineering Taught course 2018
  • Tissue Engineering Taught course 2018
  • Rsrch Exp/MCBS Taught course 2018
  • Tissue Eng Cell Culture Lab Taught course 2017
  • Tissue Engineering Taught course 2017
  • Tissue Engineering Taught course 2017
  • Education And Training

  • B.A., Colby College
  • Ph.D. Zoology/Animal Biology, University of Massachusetts - Amherst
  • Full Name

  • Don Wojchowski